Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Assets (2016 - 2025)

Historic Current Assets for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $201.7 million.

  • Medifast's Current Assets fell 593.32% to $201.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $201.7 million, marking a year-over-year decrease of 593.32%. This contributed to the annual value of $201.7 million for FY2025, which is 593.32% down from last year.
  • Medifast's Current Assets amounted to $201.7 million in Q4 2025, which was down 593.32% from $207.8 million recorded in Q3 2025.
  • Medifast's Current Assets' 5-year high stood at $324.3 million during Q1 2022, with a 5-year trough of $201.7 million in Q4 2025.
  • For the 5-year period, Medifast's Current Assets averaged around $241.7 million, with its median value being $224.6 million (2024).
  • In the last 5 years, Medifast's Current Assets soared by 7482.79% in 2021 and then plummeted by 2897.1% in 2023.
  • Over the past 5 years, Medifast's Current Assets (Quarter) stood at $306.9 million in 2021, then fell by 27.4% to $222.8 million in 2022, then increased by 0.56% to $224.0 million in 2023, then decreased by 4.3% to $214.4 million in 2024, then decreased by 5.93% to $201.7 million in 2025.
  • Its last three reported values are $201.7 million in Q4 2025, $207.8 million for Q3 2025, and $206.4 million during Q2 2025.